This Metric Says You Are Smart to Buy ISIS Pharmaceuticals, Inc. (ISIS)

Page 1 of 2

Is ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) worth your attention right now? Investors who are in the know are taking an optimistic view. The number of bullish hedge fund bets advanced by 9 in recent months.

In the financial world, there are dozens of indicators investors can use to watch Mr. Market. A couple of the most underrated are hedge fund and insider trading activity. At Insider Monkey, our studies have shown that, historically, those who follow the best picks of the best money managers can outperform the S&P 500 by a solid amount (see just how much).

Equally as integral, optimistic insider trading activity is another way to parse down the stock market universe. Just as you’d expect, there are many incentives for a corporate insider to downsize shares of his or her company, but only one, very simple reason why they would initiate a purchase. Many academic studies have demonstrated the impressive potential of this strategy if piggybackers understand what to do (learn more here).

Consequently, let’s take a gander at the key action regarding ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS).

What have hedge funds been doing with ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS)?

In preparation for this quarter, a total of 14 of the hedge funds we track were long in this stock, a change of 180% from one quarter earlier. With the smart money’s capital changing hands, there exists a few noteworthy hedge fund managers who were boosting their stakes substantially.

Of the funds we track, Visium Asset Management, managed by Jacob Gottlieb, holds the largest position in ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS). Visium Asset Management has a $17.6 million position in the stock, comprising 0.5% of its 13F portfolio. Sitting at the No. 2 spot is Millennium Management, managed by Israel Englander, which held a $11.9 million position; the fund has 0.1% of its 13F portfolio invested in the stock. Some other hedge funds that are bullish include Joseph Edelman’s Perceptive Advisors, SAC Subsidiary’s Sigma Capital Management and Louis Bacon’s Moore Global Investments.

As aggregate interest increased, key hedge funds were breaking ground themselves. Visium Asset Management, managed by Jacob Gottlieb, assembled the biggest position in ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS). Visium Asset Management had 17.6 million invested in the company at the end of the quarter. Israel Englander’s Millennium Management also made a $11.9 million investment in the stock during the quarter. The other funds with new positions in the stock are Joseph Edelman’s Perceptive Advisors, SAC Subsidiary’s Sigma Capital Management, and Louis Bacon’s Moore Global Investments.

What do corporate executives and insiders think about ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS)?

Insider buying is most useful when the company in question has seen transactions within the past six months. Over the last six-month time period, ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS) has experienced zero unique insiders buying, and 8 insider sales (see the details of insider trades here).

Let’s check out hedge fund and insider activity in other stocks similar to ISIS Pharmaceuticals, Inc. (NASDAQ:ISIS). These stocks are United Therapeutics Corporation (NASDAQ:UTHR), Cubist Pharmaceuticals Inc (NASDAQ:CBST), Amarin Corporation plc (ADR) (NASDAQ:AMRN), Taro Pharmaceutical Industries Ltd. (NYSE:TARO), and The Medicines Company (NASDAQ:MDCO). This group of stocks are the members of the drug manufacturers – other industry and their market caps resemble ISIS’s market cap.

Page 1 of 2
Comments
Insider Monkey Small Cap Strategy
Insider Monkey Small Cap Strategy

Insider Monkey beat the market by 52 percentage points in 24 months. Our beta is only 1.2 (don't click this link if beating the market isn't important to you).

Lists

The 10 Most Expensive Law Schools in the US

The 10 Best Wall Street Movies

The 10 Most Expensive Golf Clubs Ever Sold

The 10 Most Expensive Golf Memberships

The 10 Best Disney Characters Ever Created

The 8 Best Foods for Gaining Weight

The 10 Most Expensive Colleges in the World

The 7 Most Memorable Ad Campaigns of All Time

The 7 Most Expensive High Schools in the World

The 10 Electric Vehicles with the Longest Range

The 10 Cities with the Worst Drivers in the World

The 10 Most Expensive Dresses Ever Created

10 Islands to Visit Before You Die

10 Famous Celebrities Who Needed Rehab

The 15 Countries with the Largest Oil Reserves

The 10 Most Overused Excuses in the World

The 5 Best iOS Apps You Can’t Get on Android

5 Companies Damaged By Social Media Blunders

The 10 Most Legendary Blues Songs

The 10 Most Lawless Places in the World

4 Reasons China is a Threat to the US

The 17 Most Sugary Drinks in the World

The 10 Most Ruthless Rulers in History

The 10 Greatest Generals in History

Top 8 Travel Destinations for 2015

The 10 Safest Dog Breeds for Children

The 10 Most Stolen Vehicles in the US

The 7 Most Expensive Celebrity Weddings

The 10 Best LoL Teams in the World

Top 10 Worst Marketing Campaigns Ever Produced

Top 5 Diets that Help You Lose Weight

The 10 Best Ways to Stay Awake

7 Artists That Switched Musical Genres

The 10 Most Expensive Cities to Live in New Jersey

The 10 Best High Schools in New York

The 10 Countries With the Least Gender Inequality

The 6 Biggest Musician-Manager Feuds

The 10 Countries with the Cheapest Gas Prices

The 7 Most Theatrical Bands of All Time

The 8 Worst Band Breakups of All Time

The 10 Most Important South American Leaders

The 7 Most Successful Casting Show Winners

The 10 Most Peaceful Countries in the World

5 Big Reasons Communism Failed

The 15 Most Famous Carl Icahn Quotes

10 Scary Animals that are Actually Harmless

The 8 Most Famous Singer-Actors in Entertainment

The 10 Longest Wars of All Time

The 13 Worst Looking Foods that Taste Great

The 6 Most Gruesome Injuries Suffered During a Sports Match

Subscribe

Enter your email:

Delivered by FeedBurner

X

Thanks! An email with instructions is sent to !

Your email already exists in our database. Click here to go to your subscriptions

Insider Monkey returned 47.6% in its first year! Wondering How?

Download a complete edition of our newsletter for free!